LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events

On April 26, 2023, Leap Therapeutics, Inc. (the "Company") issued a press release entitled "Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting."

The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however that information on or connected to our website referenced in the Company's press release is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d)       Exhibits.



  Exhibit
   Number                                Description
    99.1       Press Release dated April 26, 2023.
    104      Cover Page Interactive Data File. (Embedded within the Inline XBRL
             document.)




                                     - 2 -

© Edgar Online, source Glimpses